CV Sciences, Inc.
Cash Flow Statement
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||
| Net Income | $-4.9M | $-14.1M | $-12.2M | $-1.3M | $-2.3M | $-45.6K | $-90.2K |
| Depreciation & Amortization | $183.0K | $1.1M | $1.0M | $933.6K | $767.3K | $0 | — |
| Depreciation | $147.0K | $195.2K | $190.3K | $112.1K | — | — | — |
| Amortization | — | — | — | $821.5K | $753.5K | — | — |
| Stock-Based Compensation | $3.4M | $2.7M | $5.7M | $7.9M | $0 | — | — |
| Net Cash from Operating Activities | $3.6M | $-2.1M | $-4.2M | $-6.7M | $-4.9M | $-64.1K | $-79.6K |
| Investing Activities | |||||||
| Capital Expenditures | $454.0K | $17.2K | $113.5K | $449.2K | $226.6K | $0 | — |
| Business Acquisitions | — | $0 | $250.0K | $0 | — | — | — |
| Net Cash from Investing Activities | $-2.0M | $852.7K | — | — | — | — | — |
| Financing Activities | |||||||
| Dividends Paid | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $119.0K | $1.7M | — | — | — | $63.3K | $50.1K |
| Net Change in Cash | — | — | — | $58.7K | $2.2M | $-737 | $-29.5K |
| Free Cash Flow | $3.2M | $-2.1M | $-4.3M | $-7.2M | $-5.1M | $-64.1K | — |